NewLink Genetics to Participate in the Jefferies 2018 Global Healthcare Conference

AMES, Iowa, May 30, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK) announced today that the company will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018, at 8:00AM ET. 

A live webcast of the presentation will be available on the Company’s website at www.newlinkgenetics.com in the “Investors & Media” section under “Events and Presentations.”  An archived edition of the presentation will be available on the Company’s website later in the day. 

About NewLink Genetics Corporation

NewLink Genetics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' leading drug candidate, indoximod, is an investigational, orally available small molecule designed to harness multiple components of the immune system to combat cancer. For more information, please visit www.newlinkgenetics.com and follow us on Twitter @NLNKGenetics.

Investor Contact:

Lisa Miller
Director of Investor Relations
NewLink Genetics
515-598-2555
[email protected]

Media Contact:

Sharon Correia
VP, Integrated Communications
LaVoieHealthScience
617-374-8800, ext. 105
[email protected]

You May Also Be Interested In

• Meet Friendly AI Assistant™: Automating “Fix My Wi-Fi”
• Lake Ridge Bancorp, Inc. Declares Third Quarter 2026 Dividend of $0.63 Per Share
• Best Lawyers in America Names 45 Wilentz, Goldman & Spitzer Attorneys to its 2027 Lists, Including Six "Lawyer of the Year" Honors